Page last updated: 2024-08-25

rosiglitazone and Bronchopulmonary Dysplasia

rosiglitazone has been researched along with Bronchopulmonary Dysplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, CW; Choi, JH; Kim, BI; Kim, EK; Kim, HS; Lee, HJ; Lee, JA; Lee, YJ	1

Other Studies

1 other study(ies) available for rosiglitazone and Bronchopulmonary Dysplasia

Article	Year
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia. Yonsei medical journal, 2014, Volume: 55, Issue:1 Topics: Animals; Bronchopulmonary Dysplasia; Female; Hypertension, Pulmonary; Immunohistochemistry; Lung; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents	2014

Article

Year

Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia.

Yonsei medical journal, 2014, Volume: 55, Issue:1

Topics: Animals; Bronchopulmonary Dysplasia; Female; Hypertension, Pulmonary; Immunohistochemistry; Lung; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents

2014